Literature DB >> 36147784

Cardiac autonomic dysfunctions in type 2 diabetes mellitus: an investigative study with heart rate variability measures.

Anu Panackal Purackal John1, Kaviraja Udupa1, Santhosh Avangapur1, Magadi Umeshchandra Sujan1,2, Ganagarajan Inbaraj1, Prathyusha Parthipulli Vasuki3, Anita Mahadevan4, Rudramunisetty Anilkumar5, Mysore AnkeGowda Shekar5, Talakad Narasappa Sathyaprabha1.   

Abstract

Cardiac autonomic neuropathy (CAN) is a common yet underdiagnosed complication of Type 2 diabetes mellitus (T2DM). Heart rate variability (HRV), a sensitive diagnostic marker of cardiovascular risk, could help detect CAN at its earliest stage. However, the progression of CAN based on age and disease duration in T2DM is lacking. In this study, we propose to explore the occurrence of CAN in patients with varying stages and duration of T2DM. This cross-sectional study involves participants with T2DM (n = 160) and healthy volunteers (n = 40) with an age range of 30-60 years of both genders. Patients in the T2DM group were further subdivided into four subgroups based on their disease duration [Prediabetes, disease duration <5 yrs (D1), 5-10 yrs (D2), and >10 yrs (D3)]. All participants underwent short-term HRV recording for 20 minutes and analyzed for both time and frequency domain measures. The study results showed a significant increase in Heart Rate (HR) in D1 (P = 0.031) and D3 (P = 0.001) groups compared to healthy controls. The time-domain measures of HRV were significantly reduced in the T2DM group compared to the healthy controls. Furthermore, this reduction is more intense in the D3 group than in D2 and D1. Correspondingly, in frequency domain parameters: total power, high-frequency power, and low-frequency power were significantly reduced in all the T2DM groups compared to healthy controls. The study concludes that the overall HRV (as determined by total power), sympathetic activity (low frequency power) and parasympathetic activity (time domain measures and high frequency power) were significantly reduced in all the diabetic subgroups except prediabetes as compared to the healthy controls, implying that both sympathetic and parasympathetic limbs are symmetrically affected in T2DM patients even in the earliest stages (<5 yrs) implying subclinical cardiac autonomic dysfunction in the earliest stages. AJCD
Copyright © 2022.

Entities:  

Keywords:  Autonomic nervous system; cardiac autonomic neuropathy; heart rate; heart rate variability; sympathetic and parasympathetic activity; type 2 diabetes mellitus

Year:  2022        PMID: 36147784      PMCID: PMC9490161     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  30 in total

Review 1.  Psychosomatics and psychopathology: looking up and down from the brain.

Authors:  Julian F Thayer; Jos F Brosschot
Journal:  Psychoneuroendocrinology       Date:  2005-11       Impact factor: 4.905

2.  Both Prediabetes and Type 2 Diabetes Are Associated With Lower Heart Rate Variability: The Maastricht Study.

Authors:  Charlotte Coopmans; Tan Lai Zhou; Ronald M A Henry; Jordi Heijman; Nicolaas C Schaper; Annemarie Koster; Miranda T Schram; Carla J H van der Kallen; Anke Wesselius; Robert J A den Engelsman; Harry J G M Crijns; Coen D A Stehouwer
Journal:  Diabetes Care       Date:  2020-03-11       Impact factor: 19.112

3.  The relationship between glycaemic variability and cardiovascular autonomic dysfunction in patients with type 1 diabetes: A systematic review.

Authors:  Simon Helleputte; Tine De Backer; Bruno Lapauw; Samyah Shadid; Bert Celie; Birgit Van Eetvelde; Karsten Vanden Wyngaert; Patrick Calders
Journal:  Diabetes Metab Res Rev       Date:  2020-03-03       Impact factor: 4.876

Review 4.  Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment.

Authors:  D Ziegler
Journal:  Diabetes Metab Rev       Date:  1994-12

5.  Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications.

Authors:  D J Ewing; I W Campbell; B F Clarke
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

6.  Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.

Authors:  Vincenza Spallone; Dan Ziegler; Roy Freeman; Luciano Bernardi; Simona Frontoni; Rodica Pop-Busui; Martin Stevens; Peter Kempler; Jannik Hilsted; Solomon Tesfaye; Phillip Low; Paul Valensi
Journal:  Diabetes Metab Res Rev       Date:  2011-10       Impact factor: 4.876

7.  Standardized tests of heart rate variability for autonomic function tests in healthy Koreans.

Authors:  Sat Byul Park; Byung Chae Lee; Kee Sam Jeong
Journal:  Int J Neurosci       Date:  2007-12       Impact factor: 2.292

8.  Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study.

Authors:  D Liao; R P Sloan; W E Cascio; A R Folsom; A D Liese; G W Evans; J Cai; A R Sharrett
Journal:  Diabetes Care       Date:  1998-12       Impact factor: 19.112

9.  Neuropathy profile of diabetic patients in a pancreas transplantation program.

Authors:  W R Kennedy; X Navarro; D E Sutherland
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910

Review 10.  Cardiac Autonomic Neuropathy: Why Should Cardiologists Care about That?

Authors:  Andrzej Bissinger
Journal:  J Diabetes Res       Date:  2017-10-29       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.